3rd Edition of International Cancer & Immuno-Oncology Conference
March 15-17, 2027 | Singapore
Cell Signaling and Cancer Pathways Researcher
A Cell Signaling and Cancer Pathways Researcher is at the forefront of understanding how disruptions in cellular communication lead to cancer. Within every cell, signaling pathways control critical functions like growth, differentiation, and programmed cell death. When these signals are misregulated—due to genetic mutations, environmental triggers, or epigenetic changes—normal cells can transform into cancerous ones. Researchers in this field study key pathways such as MAPK/ERK, PI3K/AKT, JAK/STAT, and Wnt/β-catenin, all of which are commonly altered in various cancer types. Their goal is to map out these pathways in detail, identify the specific molecular aberrations driving malignancy, and uncover how these signals interact and evolve during tumor progression.
By leveraging tools like next-generation sequencing, proteomics, single-cell analysis, and molecular imaging, these researchers provide critical insights into how cancers resist therapy, metastasize, or evade immune detection. Their work is vital for developing targeted cancer therapies—drugs that inhibit specific components of dysregulated signaling pathways—while minimizing damage to healthy cells. Additionally, they often collaborate with clinicians and pharmaceutical companies to translate lab discoveries into clinical treatments. In doing so, Cell Signaling and Cancer Pathways Researchers contribute not only to our understanding of cancer biology but also to the development of more precise, personalized, and effective therapeutic strategies.
Rajvir Dahiya
University of California San Francisco, United States
Thomas Jay Webster
Brown University, United States
Yan Leyfman
NYP- Meyer Cancer Center, United StatesSubmit your abstract Today
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States